Annette E. Fleckenstein

Annette E. Fleckenstein, MS, PhD

Languages spoken: English

Academic Information

Departments Primary -

Academic Office Information

annette.fleckenstein@hsc.utah.edu

Research Interests

  • Neuropharmacology
  • Neurochemistry
  • Aminergic Transporters
  • Addiction

Education History

Postdoctoral Fellowship University of Utah
 Postdoctoral Fellow
National Institutes of Health, National Institute on Drug Abuse - Addiction Research Center
 Postdoctoral Fellow
Doctoral Training Michigan State University
 PhD
Western Michigan University
 MS
Undergraduate Western Michigan University
 BS

Selected Publications

Journal Article

  1. Curtin K, Fleckenstein AE, Keeshin BR, Yurgelun-Todd DA, Renshaw PF, Smith KR, Hanson GR (2018). Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 43(13), 2548-2555.
  2. German CL, Gudheti MV, Fleckenstein AE, Jorgensen EM (2017). Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods Mol Biol, 1663, 153-162.
  3. Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein AE (2016). Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol, 27(5), 422-30.
  4. Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins RA (2016). Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse, 70(8), 336-46.
  5. Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe KA (2016). An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse, 70(4), 139-46.
  6. Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein AE (2015). Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther, 355(3), 463-72.
  7. German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015). Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev, 67(4), 1005-24.
  8. Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein AE (2015). Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol, 18(12).
  9. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2015). Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology, 93, 146-54.
  10. Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8.
  11. Baladi MG, Nielsen SM, Umpierre A, Hanson GR, Fleckenstein AE (2014). Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol, 25(8), 758-65.
  12. German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson GR (2014). Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse, 68(12), 634-640.
  13. German CL, Hoonakker AH, Fleckenstein AE, Hanson GR (2014). Mephedrone alters basal ganglia and limbic neurotensin systems. J Neurochem, 130(3), 402-7.
  14. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2014). Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor. Int J Neuropsychopharmacol, 17(8), 1315-20.
  15. Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein AE (2014). Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia. Eur J Pharmacol, 732, 105-10.
  16. German CL, Fleckenstein AE, Hanson GR (2014). Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci, 97(1), 2-8.

Book

  1. Hanson GR, Venturelli PJ, Fleckenstein AE (in preparation). Drugs and Society (14th Edition). Boston, MA: Jones and Bartlett.
  2. Hanson GR, Venturelli PJ, Fleckenstein AE (2018). Drugs and Society (13th Edition). Boston, MA: Jones and Bartlett.
  3. Hanson GR, Venturelli PJ, Fleckenstein AE (2015). Drugs and Society (12th Edition). Boston, MA: Jones and Bartlett.
  4. Hanson GR, Venturelli PJ, Fleckenstein AE (2012). Drugs and Society (11th Edition). Boston, MA: Jones and Bartlett.
  5. Hanson GR, Venturelli PJ, Fleckenstein AE (2008). Drugs and Society (10th Edition). Boston, MA: Jones and Bartlett.
  6. Hanson GR, Venturelli PJ, Fleckenstein AE (2004). Drugs and Society (8th Edition). Boston, MA: Jones and Bartlett.
  7. Hanson GR, Venturelli PJ, Fleckenstein AE (2002). Drugs and Society (7th Edition). Boston, MA: Jones and Bartlett.
  8. Hanson GR, Venturelli PJ, Fleckenstein AE, contributing author (2000). Drugs and Society (6th Edition). Boston, MA: Jones and Bartlett.